The Clinical and Molecular Epidemiology Shared Resource (CMESR) was established in 2000 as a repository of human biologic specimens and linked epidemiologic data for cancer biomarker studies, and it became a full shared resource in 2002. The CMESR is a source of biologic samples (blood components, buccal cells, and extracted DNA) linked to clinical and epidemiologic data from subjects with and without cancer. Breast, lung, prostate, head and neck, and colorectal cancers are included at the present time. With such a resource, the Lombardi Comprehensive Cancer Center (Lombardi) can fulfill its mission to conduct population studies of cancer risk factors and prevention. By accruing subjects and collecting their biologic samples at Lombardi and the Washington Hospital Center (MedStar Health, a sister institution in Washington, DC), the CMESR has grown to become a comprehensive resource for the Lombardi scientific community, both in terms of supplying linked data and specimens to investigators, and conducting pilot studies to accrue such materials (e.g., as preliminary data in support of grant applications). Personnel from the CMESR approach cancer and non-cancer subjects in the clinic and obtain consent to collect specimens and administer questionnaires, and the subjects agree to allow these materials to be shared with investigators. Researchers from different Lombardi programs have used these materials to develop biomarkers of early detection, progression, recurrence and prognosis, for studies of cancer risk, and for studies assessing the utillzation of screening and counseling resources by cancer patients. This resource offers additional services for its users, including customized data reports on clinical and epidemiologic characteristics of the study subjects, with information on outcomes and follow-up;and high-quality data entry for questionnaires, food frequency surveys, and other research forms. Twenty-two projects in three Lombardi programs were supported by the CMESR in 2008. Dr. Christopher Loffredo, the Director of the resource, is a cancer epidemiologist with a laboratory-based background in toxicology. The CMESR has two Associate Directors with complementary expertise: Dr. Celia Byrne, an epidemiologist with expertise in study design and evaluation, and Dr. Yun-Ling Zheng, a molecular epidemiologist with expertise in cancer genetics and a wide array of laboratory techniques.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Georgetown University
United States
Zip Code
Bae, Woo Kyun; Yoo, Kyung Hyun; Lee, Ji Shin et al. (2015) The methyltransferase EZH2 is not required for mammary cancer development, although high EZH2 and low H3K27me3 correlate with poor prognosis of ER-positive breast cancers. Mol Carcinog 54:1172-80
Adams, Inez; Christopher, Juleen; Williams, Karen Patricia et al. (2015) What Black Women Know and Want to Know About Counseling and Testing for BRCA1/2. J Cancer Educ 30:344-52
Butrick, Morgan; Kelly, Scott; Peshkin, Beth N et al. (2015) Disparities in uptake of BRCA1/2 genetic testing in a randomized trial of telephone counseling. Genet Med 17:467-75
London, Laricca; Hurtado-de-Mendoza, Alejandra; Song, Minna et al. (2015) Motivators and barriers to Latinas' participation in clinical trials: the role of contextual factors. Contemp Clin Trials 40:74-80
Mays, Darren; Niaura, Raymond S; Evans, W Douglas et al. (2015) Cigarette packaging and health warnings: the impact of plain packaging and message framing on young smokers. Tob Control 24:e87-92
Zhi, Xiuling; Lin, Ling; Yang, Shaoxian et al. (2015) ?II-Spectrin (SPTBN1) suppresses progression of hepatocellular carcinoma and Wnt signaling by regulation of Wnt inhibitor kallistatin. Hepatology 61:598-612
Rush, Christina L; Darling, Margaret; Elliott, Maria Gloria et al. (2015) Engaging Latina cancer survivors, their caregivers, and community partners in a randomized controlled trial: Nueva Vida intervention. Qual Life Res 24:1107-18
Heckler, Mary Mazzotta; Riggins, Rebecca B (2015) ERR? splice variants differentially regulate cell cycle progression. Cell Cycle 14:31-45
Kim, B; Wang, S; Lee, J M et al. (2015) Synthetic lethal screening reveals FGFR as one of the combinatorial targets to overcome resistance to Met-targeted therapy. Oncogene 34:1083-93
Tong, Angie; Kelly, Scott; Nusbaum, Rachel et al. (2015) Intentions for risk-reducing surgery among high-risk women referred for BRCA1/BRCA2 genetic counseling. Psychooncology 24:33-9

Showing the most recent 10 out of 544 publications